Evotec stock rises at the close after conference plans
Published on 09/22/2026 at 22:58 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Evotec stock closed at a U.S.-dollar level on September 22, 2026, on its U.S. venue, with the session change reported against the prior close. The U.S.-listed security also faced a biotechnology market backdrop in which the Nasdaq Composite finished 2.3 percent higher at 27,122.09.
September 22, 2026 session profile
Evotec SE (ISIN DE0005664809) traded in the United States as an ADR-linked security, while its home-market shares reached a 52-week low in Xetra trading during the session. The Xetra shares later traded 1.4 percent higher at 2.83 euros at 10:28 a.m. ET, a home-market move that cannot be used as the U.S. closing price.
The latest U.S. venue reference available for Evotec ADRs was a September 21, 2026 last trade of USD 1.5550, following a prior close of USD 1.60 and volume of 99,869 shares. The Nasdaq Composite's 2.3 percent advance provided the dated market comparison for the U.S. session.
Evotec event on September 23, 2026
As Ad hoc news reported, Evotec is scheduled to present at the BioProcess International US East 2026 conference in Boston on September 23 and 24, 2026.
